Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase 2 9Phase EARLY_PHASE1 3Phase 4 3Phase 3 3Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Probiotics × Clear all
NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT04593459 2024-03-22

ProPCO-RCT

Medical University of Graz

Phase 4 Completed
112 enrolled

Polycystic Ovary Syndrome

NCT05730777 2023-02-16

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Peking University Third Hospital

Phase 4 Unknown
200 enrolled

Cancer Therapy-related Cardiovascular Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡